Literature DB >> 8948515

Ovalbumin challenge following immunization elicits recruitment of eosinophils but not bronchial hyperresponsiveness in guinea-pigs: time course and relationship to eosinophil activation status.

K H Banner1, W Paul, C P Page.   

Abstract

Eosinophils are known to be present in the airways of allergic asthmatics, and have been suggested to contribute to the pathophysiological changes accompanying this condition, particularly hyperresponsiveness to airway spasmogens. However, a causal relationship between pulmonary eosinophil accumulation and bronchial hyperresponsiveness in asthma is not proven. In the present study, the time course of pulmonary cell influx was investigated in an immunized guinea-pig model. Eosinophil activation status was also determined together with the bronchial responsiveness to histamine. Guinea-pigs were sensitized [20 micrograms ovalbumin (OVA) per animal in A1(OH)3 (0.5 ml) i.p.] and subsequently challenged with aerosolized OVA (100 micrograms/ml) for 1 h 18-21 days later. At different time points (1 h to 72 h) after OVA challenge, bronchial responses to i.v. histamine were measured and bronchoalveolar lavage (BAL) was performed to assess pulmonary cell influx. Eosinophil peroxidase (EPO) and total protein levels were measured in BAL fluid supernatants. Exposure of sensitized animals to aerosolized OVA produced a significant increase (P < 0.05 vs. sham immunized) in eosinophil infiltration 24 h later which was sustained up to 72 h. Despite this, OVA challenge did not cause either eosinophil activation, as measured by EPO release, or bronchial hyperresponsiveness to histamine at any of the time points examined. These data show that allergen challenge of sensitized guinea-pigs can elicit airway eosinophil accumulation without accompanying airways hyperresponsiveness or eosinophil activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8948515     DOI: 10.1006/pulp.1996.0021

Source DB:  PubMed          Journal:  Pulm Pharmacol        ISSN: 0952-0600


  3 in total

1.  Role of airway eosinophilia and eosinophil activation in Sephadex-induced inflammation.

Authors:  Karim Maghni; François Nantel; Chantal Lanoue; Solange Cloutier; Jean-Paul Cristol; Alain Cadieux; Pierre Sirois
Journal:  Inflammation       Date:  2004-08       Impact factor: 4.092

2.  Laser-engineered dissolving microneedle arrays for protein delivery: potential for enhanced intradermal vaccination.

Authors:  Maelíosa T C McCrudden; Barbara M Torrisi; Sharifah Al-Zahrani; Cian M McCrudden; Marija Zaric; Christopher J Scott; Adrien Kissenpfennig; Helen O McCarthy; Ryan F Donnelly
Journal:  J Pharm Pharmacol       Date:  2014-03-27       Impact factor: 3.765

Review 3.  Animal models of allergic asthma.

Authors:  Heidi Isenberg-Feig; J Paul Justice; Andrea Keane-Myers
Journal:  Curr Allergy Asthma Rep       Date:  2003-01       Impact factor: 4.919

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.